Home/Filings/4/0001225208-09-022362
4//SEC Filing

MULLARKEY MATTHEW T 4

Accession 0001225208-09-022362

CIK 0000105770other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:58 AM ET

Size

6.2 KB

Accession

0001225208-09-022362

Insider Transaction Report

Form 4
Period: 2009-11-13
MULLARKEY MATTHEW T
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2009-11-13$38.18/sh+18.13$69243.873 total(indirect: Non-Qualified Deferred Compensation Plan)
Holdings
  • Common Stock

    377.453
  • Common Stock

    (indirect: By Savings Plan)
    90.904
Footnotes (1)
  • [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

Documents

1 file

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001238088

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:58 AM ET
Size
6.2 KB